Details for 2018868404
Up to date per 03.04.2026
Actions
Details for 2018868404
Granted/Registered
European Patent
29.07.2020 A
07.12.2022 B1
20.10.2017
US
201762575358 P
A61K 31/7088 20060101AFI20211210BHEP
Owner
Dicerna Pharmaceuticals, Inc.75 Hayden Avenue Lexington, MA 02421US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
KOSER, Martin Lexington MA 02421US
ABRAMS, Marc Lexington, MA 02421US
Information about Fees